Inventor
SHAW SIMON
US37 patents
⚠️ This page may combine multiple inventors who share the name “SHAW SIMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
34 patentsUS10941134B2Mar 9, 2021
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC18 citations94
US10815206B2Oct 27, 2020
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC16 citations94
US10377742B2Aug 13, 2019
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC20 citations94
US9266856B2Feb 23, 2016
AMPK—activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC14 citations92
US8987303B2Mar 24, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8980921B2Mar 17, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8809370B2Aug 19, 2014
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC17 citations92
US11479543B2Oct 25, 2022
Heterocyclic RIP1 kinase inhibitors
RIGEL PHARMACEUTICALS INC5 citations84
US11407736B2Aug 9, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC4 citations84
US11332451B2May 17, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC3 citations84
US9663496B2May 30, 2017
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC9 citations80
US11530194B2Dec 20, 2022
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11377428B2Jul 5, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US11370764B2Jun 28, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US11370765B2Jun 28, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US10947216B2Mar 16, 2021
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10414753B2Sep 17, 2019
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11370787B2Jun 28, 2022
Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
RIGEL PHARMACEUTICALS INC4 citations71
US9409884B2Aug 9, 2016
5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
RIGEL PHARMACEUTICALS INC4 citations70
US12116354B2Oct 15, 2024
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC0 citations63
US11472782B2Oct 18, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC0 citations63
US12331036B2Jun 17, 2025
Heterocyclic RIP1 kinase inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US12297202B2May 13, 2025
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US11939317B2Mar 26, 2024
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC0 citations62
US11667643B2Jun 6, 2023
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US12441723B2Oct 14, 2025
Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
RIGEL PHARMACEUTICALS INC0 citations60
US12357623B2Jul 15, 2025
Method for treating a disease or condition using a pyrazole compound or formulation thereof
RIGEL PHARMACEUTICALS INC0 citations60
US12384775B2Aug 12, 2025
Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors
RIGEL PHARMACEUTICALS INC0 citations58
US11578078B2Feb 14, 2023
Heterocyclic RIP1 inhibitory compounds
RIGEL PHARMACEUTICALS INC0 citations52
US11564930B2Jan 31, 2023
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC0 citations52
US11174246B2Nov 16, 2021
Direct AMPK activators
RIGEL PHARMACEUTICALS INC0 citations49
US12459941B2Nov 4, 2025
Tricyclic IRAK inhibitors
RIGEL PHARMACEUTICALS INC0 citations47
US12156880B2Dec 3, 2024
Heterocyclic RIP1 kinase inhibitors
RIGEL PHARMACEUTICALS INC0 citations47
US10040766B2Aug 7, 2018
Ubiquitination inhibitors
RIGEL PHARMACEUTICALS INC0 citations37